Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM643829 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Potency of IRAK4 Inhibitor Compounds in IRAK4 Enzyme Assay | ||
IC50 | 0.700±n/a nM | ||
Citation | Terstiege, I; Schiesser, S; Xue, Y; Chang, H; Berggren, AI Substituted indazoles as IRAK4 inhibitors US Patent US11866405 Publication Date 1/9/2024 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM643829 | |||
n/a | |||
Name | BDBM643829 | ||
Synonyms: | US11866405, Example 97 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H31N7O4 | ||
Mol. Mass. | 517.5795 | ||
SMILES | COc1cc2nn(cc2cc1C(=O)Nc1cnn2cccnc12)C1CC[C@@H](CC1)N(C)C(=O)[C@H]1C[C@H](O)C1 |r,wU:33.37,wD:26.33,35.40,(5.74,-3.24,;5.74,-1.7,;4.4,-.93,;3.07,-1.7,;1.73,-.93,;.27,-1.4,;-.64,-.16,;.27,1.09,;1.73,.61,;3.07,1.38,;4.4,.61,;5.74,1.38,;5.74,2.92,;7.07,.61,;8.4,1.38,;8.56,2.92,;10.07,3.24,;10.84,1.9,;12.35,1.58,;12.82,.12,;11.79,-1.03,;10.29,-.71,;9.81,.76,;-2.18,-.16,;-2.94,-1.49,;-4.49,-1.49,;-5.25,-.16,;-4.49,1.18,;-2.94,1.18,;-6.79,-.16,;-7.56,1.18,;-7.56,-1.49,;-6.79,-2.82,;-9.1,-1.49,;-10.19,-2.58,;-11.28,-1.49,;-12.82,-1.49,;-10.19,-.4,)| | ||
Structure |